Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Roche

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Annales D'Endocrinologie|January 1, 1992
[Contribution of intra-operative measurement of intact parathormone in surgery for primary hyperparathyroidism]M Duquenne, O Roche, N De Talance, et al.
Alcoholism, Clinical and Experimental Research|June 13, 2021
A meta-regression of methodological features that predict the effects of medications on the subjective response to alcoholReJoyce Green, Han Du, Erica N Grodin, et al.
Psychopharmacology|March 31, 2017
Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorderDaniel J O Roche, Matthew J Worley, Kelly E Courtney, et al.
Journal Francais D'Ophtalmologie|October 27, 2005
[Conjunctival tumors in children. A histopathologic study of 42 cases]F Beby, L Kodjikian, O Roche, et al.
Presse Medicale (Paris, France : 1983)|September 2, 1995
[Pseudomonas aeruginosa septicemia. Host-related risk factors in 82 episodes]O Roche, F Beuhorry-Sassus, A Boillot, et al.
Alcoholism, Clinical and Experimental Research|April 19, 2016
A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use DisorderDaniel J O Roche, Megan M Yardley, Katy F Lunny, et al.
Journal of Dual Diagnosis|September 28, 2021
A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use DisorderAshton E Clark, Shelby R Goodwin, Russell M Marks, et al.
Eye (London, England)|January 16, 2010
New ocular phenotype associated with a mutation in the PAX2 geneF Beby, O Roche, P Cochat, et al.
Psychopharmacology|December 1, 2025
Individual and additive effects of childhood maltreatment and substance use disorder histories on baseline and stress-induced changes in peripheral stress biomarkersAbigail R Lunge, Lars Östman, Ryann Tansey, et al.
British Journal of Pharmacology|September 16, 2009
Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptorP Malherbe, E Borroni, L Gobbi, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Annales D'Endocrinologie|January 1, 1992
[Contribution of intra-operative measurement of intact parathormone in surgery for primary hyperparathyroidism]M Duquenne, O Roche, N De Talance, et al.
Alcoholism, Clinical and Experimental Research|June 13, 2021
A meta-regression of methodological features that predict the effects of medications on the subjective response to alcoholReJoyce Green, Han Du, Erica N Grodin, et al.
Psychopharmacology|March 31, 2017
Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorderDaniel J O Roche, Matthew J Worley, Kelly E Courtney, et al.
Journal Francais D'Ophtalmologie|October 27, 2005
[Conjunctival tumors in children. A histopathologic study of 42 cases]F Beby, L Kodjikian, O Roche, et al.
Presse Medicale (Paris, France : 1983)|September 2, 1995
[Pseudomonas aeruginosa septicemia. Host-related risk factors in 82 episodes]O Roche, F Beuhorry-Sassus, A Boillot, et al.
Alcoholism, Clinical and Experimental Research|April 19, 2016
A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use DisorderDaniel J O Roche, Megan M Yardley, Katy F Lunny, et al.
Journal of Dual Diagnosis|September 28, 2021
A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use DisorderAshton E Clark, Shelby R Goodwin, Russell M Marks, et al.
Eye (London, England)|January 16, 2010
New ocular phenotype associated with a mutation in the PAX2 geneF Beby, O Roche, P Cochat, et al.
Psychopharmacology|December 1, 2025
Individual and additive effects of childhood maltreatment and substance use disorder histories on baseline and stress-induced changes in peripheral stress biomarkersAbigail R Lunge, Lars Östman, Ryann Tansey, et al.
British Journal of Pharmacology|September 16, 2009
Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptorP Malherbe, E Borroni, L Gobbi, et al.
Pageof 14